Recent News

• 05.13.2026 - Aquestive Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
• 05.12.2026 - Aquestive Therapeutics Completes $150 Million Debt Refinancing with Oaktree

Recent Filings

• 05.11.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.07.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.07.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.07.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.07.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.07.2026 - 4 Statement of changes in beneficial ownership of securities
• 04.24.2026 - DEF 14A Other definitive proxy statements
• 04.24.2026 - ARS Annual Report to Security Holders
• 04.24.2026 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.13.2026 - 4 Statement of changes in beneficial ownership of securities